Biological and clinical significance of cytogenetic abnormalities in low-risk and high-risk gastrointestinal stromal tumors
- 1 March 2002
- journal article
- Published by Elsevier in Human Pathology
- Vol. 33 (3) , 316-321
- https://doi.org/10.1053/hupa.2002.32216
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Gastrointestinal stromal tumors: Recent advances in understanding of their biologyPublished by Elsevier ,2004
- Loss of 14q and 22q in Gastrointestinal Stromal Tumors (Pacemaker Cell Tumors)Cancer Genetics and Cytogenetics, 2000
- Putative chromosomal deletions on 9p, 9q and 22q occur preferentially in malignant gastrointestinal stromal tumorsInternational Journal of Cancer, 2000
- Interstitial Cells of Cajal as Precursors of Gastrointestinal Stromal TumorsThe American Journal of Surgical Pathology, 1999
- Different patterns of DNA copy number changes in gastrointestinal stromal tumors, lelomyomas, and schwannomasHuman Pathology, 1998
- Gastrointestinal Stromal Tumor, Uncommitted Type, with Monosomies 14 and 22 as the Only Chromosomal AbnormalitiesCancer Genetics and Cytogenetics, 1998
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- Differentiation and Risk Assessment of Gastrointestinal Stromal TumorsAmerican Journal of Clinical Pathology, 1995
- Recurrent chromosome aberrations in abdominal smooth muscle tumorsCancer Genetics and Cytogenetics, 1992
- Three possible cytogenetic subgroups of leiomyosarcomaCancer Genetics and Cytogenetics, 1989